Cargando…
Risks of paxlovid in a heart transplant recipient
The burden of morbidity and mortality from SARS-CoV-2 infection is especially significant in heart transplant patients who are at higher risk for poor outcomes owing to immunosuppression, blunted response to vaccination, and multiple comorbid conditions. Over the last 3 years the therapeutic landsca...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society for Heart and Lung Transplantation.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452411/ https://www.ncbi.nlm.nih.gov/pubmed/36344373 http://dx.doi.org/10.1016/j.healun.2022.08.029 |